Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42,079,879
-
Total 13F shares
-
14,061,920
-
Share change
-
+1,144,865
-
Total reported value
-
$31,922,818
-
Price per share
-
$2.27
-
Number of holders
-
36
-
Value change
-
+$2,512,314
-
Number of buys
-
16
-
Number of sells
-
8
Institutional Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q2 2025
As of 30 Jun 2025,
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,061,920 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, Rosalind Advisors, Inc., ORBIMED ADVISORS LLC, Soleus Capital Management, L.P., MARSHALL WACE, LLP, Parkman Healthcare Partners LLC, Velan Capital Investment Management LP, PURA VIDA INVESTMENTS, LLC, Affiance Financial, LLC, and UBS Group AG.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.